eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | portal hypertension |
| Comorbidity | C0023890|liver cirrhosis |
| Sentences | 53 |
| PubMedID- 23247799 | 1endoscopic appearance of small bowel lesions related to portal hypertension in patients with liver cirrhosis. |
| PubMedID- 24339715 | Severe chronic illness included liver cirrhosis with portal hypertension, new york heart association class iv congestive heart failure, chronic respiratory disease, end-stage renal disease, or an immune-compromised state (e.g., leukemia, lymphoma, or aids). |
| PubMedID- 25374728 | Variceal bleeding is the major complication of portal hypertension in patients with liver cirrhosis. |
| PubMedID- 26516439 | The american association for the study of liver diseases (aasld) and the european association for the study of the liver (easl) have established guidelines that indicate that liver cirrhosis with portal hypertension is a relative contraindication for hepatic resection because of the high risk liver failure after the operation (14–17). |
| PubMedID- 25543221 | liver cirrhosis with portal hypertension is also associated with the presence of pahs in 1-2% of cases. |
| PubMedID- 22577563 | portal hypertension in liver cirrhosis results from the anatomical changes and the development of contractile element in the liver vascular bed secondary to progressive hepatic fibrosis and formation of regenerative nodules [1, 2]. |
| PubMedID- 23547461 | [the protective effect of n-acetylcysteine magnesium against liver cirrhosis with portal hypertension in rat]. |
| PubMedID- 24949616 | Partial splenic embolization is an effective interventional procedure performed in liver cirrhosis complicated with portal hypertension to improve the low platelet count. |
| PubMedID- 23452051 | Functional variants of enos and inos genes have no relationship to the portal hypertension in patients with liver cirrhosis. |
| PubMedID- 20653965 | Patent paraumbilical and abdominal subcutaneous veins are found frequently as collaterals in patients due to portal hypertension, mainly associated with liver cirrhosis [1,2]. |
| PubMedID- 21506350 | An analysis of 115 liver cirrhosis patients with portal hypertension was made to find out which of them had variceal bleeding and high risk of its development. |
| PubMedID- 22957328 | Liver elastography for the diagnosis of portal hypertension in patients with liver cirrhosis. |
| PubMedID- 20652243 | Four patients underwent splenectomy because of liver cirrhosis with portal hypertension and gastroesophageal variceal bleeding. |
| PubMedID- 25892988 | This study aimed to further investigate portal venous remodeling in the pathogenesis of liver cirrhosis with portal hypertension, thereby guiding its prevention and treatment. |
| PubMedID- 26159275 | This might explain the pathophysiologic correlation between microbial infections and portal hypertension in patients with liver cirrhosis. |
| PubMedID- 23729979 | Portal vein interventions in liver transplant recipients represent a group of interventions in the management of several disease entities including portal vein stenosis, portal vein thrombosis, and recurrent liver cirrhosis with portal hypertension with and without gastric varices. |
| PubMedID- 21802316 | Purpose: to develop a clinically relevant porcine model of liver cirrhosis with portal hypertension by means of hepatic transarterial embolization. |
| PubMedID- 24459641 | Lsm could be a non-invasive method to predict clinically significant and severe portal hypertension in patients with liver cirrhosis in korea. |
| PubMedID- 21705304 | A detailed interview and examination by occupational health and other medical specialists revealed that the patient had been suffering from wilson's disease from the age of 13, and had now developed hepatic manifestations (compensated liver cirrhosis with portal hypertension), neurological manifestations (dystonia, dysarthria, muscle weakness, vertigo), and psychiatric manifestations (depression, insomnia, cognitive impairment) of the disease, including problems partially caused by long-lasting treatment with copper chelating agents (neurological and haematological manifestations). |
| PubMedID- 22916658 | portal hypertension and varices in patients with liver cirrhosis. |
| PubMedID- 25374673 | Future therapy of portal hypertension in liver cirrhosis - a guess. |
| PubMedID- 24775062 | Myeloproliferative disorder, liver cirrhosis with portal hypertension, deficiency of natural anticoagulant proteins such as protein c or atiii as well as hepatocellular carcinoma are the most frequent causes of portal vein thrombosis [1]. |
| PubMedID- 22009385 | Background: portal hypertension associated with liver cirrhosis increases the risk of postoperative complications after liver resection for hepatocellular carcinoma (hcc). |
| PubMedID- 25933224 | liver cirrhosis with portal hypertension is characterized by systemic and splanchnic vasodilatory substances release, especially nitric oxide (no) and prostacyclin [3], which lead to hyperdynamic circulatory status, and further increased mesenteric blood flow and portal inflow. |
| PubMedID- 24400086 | The hemodynamic alteration of portal hypertension in patients with liver cirrhosis contributes to most of the clinical manifestations of the disease: gastrointestinal bleeding, hepatic encephalopathy, ascites and renal failure. |
| PubMedID- 25336484 | Contrast-enhanced sonography for quantitative assessment of portal hypertension in patients with liver cirrhosis. |
| PubMedID- 24673975 | Thrombocytopenia: in time, liver cirrhosis leads to portal hypertension. |
| PubMedID- 25499848 | Portal hypertensive gastropathy (ghp) is a complication of portal hypertension usually associated with liver cirrhosis. |
| PubMedID- 25888771 | Introduction: esophagogastric varices bleeding is a common complication due to portal hypertension in patients with liver cirrhosis. |
| PubMedID- 23855493 | Impaired endothelial function is a major cause of portal hypertension in liver cirrhosis. |
| PubMedID- 22591184 | Soluble cd163, a marker of kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis. |
| PubMedID- 25038804 | Estimation of the severity of portal hypertension in patients with liver cirrhosis is another major use of liver stiffness measurements. |
| PubMedID- 23559324 | Olt was performed at the age of 7 years, due to liver cirrhosis with portal hypertension, in the absence of neurological lesions and an almost-normal brain mri. |
| PubMedID- 21701671 | She was a known case of cryptogenic liver cirrhosis with portal hypertension. |
| PubMedID- 24757655 | Background/aims: this retrospective study assessed the clinical outcome of a transjugular intrahepatic portosystemic shunt (tips) procedure for managing portal hypertension in koreans with liver cirrhosis. |
| PubMedID- 22114590 | Thus, despite its invasiveness, eus is a method that provides a reliable and unique assessment of the features of portal hypertension in patients with liver cirrhosis. |
| PubMedID- 24350068 | liver cirrhosis causes 90% of portal hypertension in the western world, which leads to the development of porto-systemic collaterals, this in turn triggers the formation of the lower esophageal and gastric cardiac varices. |
| PubMedID- 24974920 | So, the current study was conducted to evaluate cardiac systolic and diastolic functions in liver cirrhosis patients with portal hypertension by conventional doppler echocardiography and tdi. |
| PubMedID- 21827004 | Reconstructed cta images showed that different collateral vessels were developed at the end-stage of chronic liver cirrhosis due to severe portal hypertension. |
| PubMedID- 24914368 | Selection of a tips stent for management of portal hypertension in liver cirrhosis: an evidence-based review. |
| PubMedID- 24502094 | Results: sixteen patients were found to have liver cirrhosis, three of them with portal hypertension. |
| PubMedID- 24563796 | Relevant diagnoses of the patient were (i) known hypertensive cardiac disease (transthoracic echocardiography 6 months before had shown a lv-ef of 54% and a light mitral and tricuspid insufficiency) and (ii) liver cirrhosis with portal hypertension. |
| PubMedID- 22878372 | This is due to the common practice of intermittent clamping of drains, because of a perceived risk of hypotension with free drainage, based on historical experience with paracentesis for transudative ascites due to hypo-albuminaemia and portal hypertension in patients with liver cirrhosis. |
| PubMedID- 21606920 | The experimental study of liver cirrhosis with portal hypertension syndrome, modeled in 38 dogs, has been performed. |
| PubMedID- 25798930 | Objective: to investigate the role of contrast-enhanced ultrasonography (ceus) and doppler ultrasonography (dus) in the diagnosis of severe portal hypertension (ph) in patients with liver cirrhosis (lc). |
| PubMedID- 25701619 | Objective: we have compared the influences of three surgical strategies on the occurrence and development of portal vein thrombosis (pvt) in patients with liver cirrhosis complicated by portal hypertension (pht) in this study. |
| PubMedID- 21460144 | Methods: spectral doppler sonography of the hepatic vein was performed on 22 consecutive patients who underwent hvpg measurement for portal hypertension with liver cirrhosis. |
| PubMedID- 24697006 | In second pregnancy, medically induced abortion was performed in the 12th week because of deterioration of the underlying disease, liver cirrhosis with portal hypertension. |
| PubMedID- 25812120 | In some patients liver fibrosis leads to liver cirrhosis with portal hypertension, hepatocellular dysfunction and increased risk of hepatocellular carcinoma [2,3]. |
| PubMedID- 24820919 | Case background: ascites appears mainly as a consequence of portal hypertension in patients with liver cirrhosis, or can be caused by several other causes, such us congestive heart failure, peritoneal malignancy, or tuberculosis. |
Page: 1 2